We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...
With list prices of $8.94 per day for the monotherapy ... the other leading market for the drugs. Merck and Pfizer began a collaboration in 2013, covering the whole world except Japan, for co ...
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...
Deutsche Bank lowered the firm’s price target on Merck (MRK) to $140 from $145 and keeps a Buy rating on the shares following the Q3 ...
Guggenheim lowered the firm’s price target on Merck (MRK) to $130 from $137 and keeps a Buy rating on the shares. While noting shares are down about 2.6% since the company reported Q3 earnings last ...
Merck reported third-quarter revenue and adjusted earnings that topped expectations. The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its ...